BW

12
May
By MetroLatinoUSA
BW

Kirby McInerney LLP Announces an Investigation of Shareholder Claims on Behalf of GoodRx Holdings, Inc. (GDRX) Investors

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX). The investigation concerns whether GoodRx has violated the federal securities laws and/or engaged in other unlawful business practices. GoodRx’s core business is a healthcare technology platform that…
Leer más...
12
May
By MetroLatinoUSA
BW

Preferred Apartment Communities, Inc. Publishes Inaugural Environmental, Social and Governance Report

ATLANTA--(BUSINESS WIRE)--Preferred Apartment Communities, Inc. (NYSE: APTS) ("PAC" or the "Company") today announced that it has published its inaugural Environmental, Social and Governance (ESG) Report. While ESG values have long been core to the Company’s business practices, this publication provides a comprehensive overview of PAC’s ESG efforts, both for the…
Leer más...
12
May
By MetroLatinoUSA
BW

Kirby McInerney LLP Announces an Investigation of Shareholder Claims on Behalf of Dentsply Sirona Inc. (XRAY) Investors

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Dentsply Sirona Inc. (“Dentsply” or the “Company”) (NASDAQ: XRAY). The investigation concerns whether Dentsply has violated the federal securities laws and/or engaged in other unlawful business practices. Dentsply is a dental equipment manufacturer and dental consumables…
Leer más...
12
May
By MetroLatinoUSA
BW

United Bankshares Declares Second Quarter Dividend

WASHINGTON & CHARLESTON, W.V.--(BUSINESS WIRE)--United Bankshares, Inc. (“United”)(NASDAQ: UBSI), today announced that its Board of Directors declared a second quarter dividend of $0.36 per share for shareholders of record as of June 10, 2022. The dividend payout of approximately $48.7 million on 135.3 million shares is payable July 1, 2022.…
Leer más...
12
May
By MetroLatinoUSA
BW

Enrollment Completed in Reflow Medical’s DEEPER OUS Clinical Trial

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--#CLIFighters--Reflow Medical, Inc. announces that it has completed patient enrollment in the DEEPER OUS clinical trial (NCT03807531) for the company’s Temporary Spur Stent System, a novel device that features a retrievable stent designed for complex infrapopliteal disease. 106 patients have now been enrolled in the prospective, nonrandomized…
Leer más...
¡Síguenos en Facebook!
¡Síguenos en Twitter!